Nivolumab Ipilimumab in Patients With hyperMutated Cancers Detected in Blood (NIMBLe)
Clinical trial NCT03461952 · TERMINATED
Trial details
- NCT number
- NCT03461952
- Sponsor
- Canadian Cancer Trials Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-11
- Primary completion
- 2021-06-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.